Global Compliance Program

Global Compliance Program

As part of our long-standing commitment to ethics and good corporate citizenship, we adopt policies and procedures to facilitate compliance with the laws and regulations that govern the way we market and sell our medicines, vaccines and other products.

We have a well-established global compliance program that is consistent with the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Code of Practice requirements, as well as other applicable regional or country industry codes of conduct, including those issued by the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industry Associations (EFPIA).

Our global compliance program is built around the core elements of an effective compliance program.

Our company’s Board of Directors and senior management, including the chief ethics and compliance officer and members of the Corporate Compliance Committee, provide the foundational elements of leadership, accountability and structure to oversee the company’s global compliance program.

The chief ethics and compliance officer reports directly to our company’s CEO and provides regular quarterly updates to the Audit Committee of the Board of Directors on key indicators of ethical culture. This reporting structure supports open communications with senior leadership regarding important developments that relate to ethics and compliance.